Efavirenz dosing in patients receiving continuous ambulatory peritoneal dialysis

AIDS

Volumn 14, Issue 8, 2000, Pages 1062-1064

  Gill, M John ^a,b   Ostrop, Nikola J ^a   Fiske, William D ^c   Brennan, James M ^c  

^a Southern Alberta Clinic   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOSARTAN; NIFEDIPINE; RITONAVIR; SAQUINAVIR; ZIDOVUDINE;

ADULT; ANEMIA; CASE REPORT; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIARRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; LETTER; MALE; PRIORITY JOURNAL;

ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXAZINES; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0034079341     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200005260-00021     Document Type: Letter

References (6)